Elevated IL-3 and IL-12p40 levels in the lower airway of infants with RSV-induced bronchiolitis correlate with recurrent wheezing

Cytokine

Volumn 76, Issue 2, 2015, Pages 417-423

  Bertrand, Pablo ^a   Lay, Margarita K ^b   Piedimonte, Giovanni ^d   Brockmann, Pablo E ^a   Palavecino, Christian E ^b   Hernández, Jury ^a   León, Miguel A ^b   Kalergis, Alexis M ^a,b,c   Bueno, Susan M ^a,b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c INSERM   (France)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Asthma; Bronchiolitis; Interleukin 12p40; Interleukin 3; Respiratory Syncytial Virus; T helper 2

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; INTERLEUKIN 12; MESSENGER RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFANT; LOWER RESPIRATORY TRACT; LUNG LAVAGE; MALE; NASOPHARYNGEAL ASPIRATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECURRENT DISEASE; VIRAL BRONCHIOLITIS; WHEEZING; ABNORMAL RESPIRATORY SOUND; BRONCHIOLITIS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHUS; CASE CONTROL STUDY; GENETICS; METABOLISM; RESPIRATORY SYNCYTIAL VIRUS INFECTION;

BRONCHI; BRONCHIOLITIS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT; INTERLEUKIN-12; INTERLEUKIN-3; MALE; RECURRENCE; RESPIRATORY SOUNDS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RNA, MESSENGER;

EID: 84943818226     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.07.017     Document Type: Article

References (50)

1. Robinson R.F. Impact of respiratory syncytial virus in the United States. Am. J. Health Syst. Pharm. 2008, 65:S3-S6.
2. Monto A.S. Epidemiology of viral respiratory infections. Am. J. Med. 2002, 112(Suppl 6A):4S-12S.
3. Iwane M.K., Edwards K.M., Szilagyi P.G., Walker F.J., Griffin M.R., Weinberg G.A., et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004, 113:1758-1764.
4. Mohapatra S.S., Boyapalle S. Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma. Clin. Microbiol. Rev. 2008, 21:495-504.
5. Sigurs N., Aljassim F., Kjellman B., Robinson P.D., Sigurbergsson F., Bjarnason R., et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 2010, 65:1045-1052.
6. Carroll K.N., Wu P., Gebretsadik T., Griffin M.R., Dupont W.D., Mitchel E.F., et al. The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma. J. Allergy Clin. Immunol. 2009, 123:1055-1061. 61 e1.
7. Martinez F.D., Wright A.L., Taussig L.M., Holberg C.J., Halonen M., Morgan W.J. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N. Engl. J. Med. 1995, 332:133-138.
8. Mackenzie K.J., Anderton S.M., Schwarze J. Viral respiratory tract infections and asthma in early life: cause and effect?. Clin. Exp. Allergy: J. Brit. Soc. Allergy Clin. Immunol. 2014, 44:9-19.
9. McNamara P.S., Ritson P., Selby A., Hart C.A., Smyth R.L. Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch. Dis. Child. 2003, 88:922-926.
10. Lay M.K., Gonzalez P.A., Leon M.A., Cespedes P.F., Bueno S.M., Riedel C.A., et al. Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response. Microbes Infect. 2013, 15:230-242.
11. Fiedler M.A., Wernke-Dollries K., Stark J.M. Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells. Am. J. Physiol. 1995, 269:L865-L872.
12. Thomas L.H., Friedland J.S., Sharland M., Becker S. Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-kappa B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of kappa B alpha. J. Immunol. 1998, 161:1007-1016.
13. Jaovisidha P., Peeples M.E., Brees A.A., Carpenter L.R., Moy J.N. Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release. J. Immunol. 1999, 163:2816-2820.
14. Villenave R., Thavagnanam S., Sarlang S., Parker J., Douglas I., Skibinski G., et al. In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc. Natl. Acad. Sci. USA 2012, 109:5040-5045.
15. Roman M., Calhoun W.J., Hinton K.L., Avendano L.F., Simon V., Escobar A.M., et al. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am. J. Respir. Crit. Care Med. 1997, 156:190-195.
16. Ehlenfield D.R., Cameron K., Welliver R.C. Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease. Pediatrics 2000, 105:79-83.
17. Robinson D.S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A.M., et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 1992, 326:298-304.
18. Openshaw P.J., Clarke S.L., Record F.M. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int. Immunol. 1992, 4:493-500.
19. Hui C.C., Murphy D.M., Neighbour H., Al-Sayegh M., O'Byrne S., Thong B., et al. T cell-mediated induction of thymic stromal lymphopoietin in differentiated human primary bronchial epithelial cells. Clin. Exp. Allergy: J. Brit. Soc. Allergy Clin. Immunol. 2014, 44:953-964.
20. Beale J., et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci. Transl. Med. 2014, 6(256). 256ra134.
21. Jackson D.J., et al. IL-33-Dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am. J. Respir. Crit. Care Med. 2014, 190(12):1373-1382.
22. Yagami A., Orihara K., Morita H., Futamura K., Hashimoto N., Matsumoto K., et al. IL-33 mediates inflammatory responses in human lung tissue cells. J. Immunol. 2010, 185:5743-5750.
23. Besnard A.G., Togbe D., Guillou N., Erard F., Quesniaux V., Ryffel B. IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur. J. Immunol. 2011, 41:1675-1686.
24. Al-Shami A., Spolski R., Kelly J., Keane-Myers A., Leonard W.J. A role for TSLP in the development of inflammation in an asthma model. J. Exp. Med. 2005, 202:829-839.
25. Sheeran P., Jafri H., Carubelli C., Saavedra J., Johnson C., Krisher K., et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr. Infect. Dis. J. 1999, 18:115-122.
26. Bierman C.W., Pierson W.E. The pharmacologic management of status asthmaticus in children. Pediatrics 1974, 54:245-247.
27. Tal A., Bavilski C., Yohai D., Bearman J.E., Gorodischer R., Moses S.W. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics 1983, 71:13-18.
28. Lewis T.C., Henderson T.A., Carpenter A.R., Ramirez I.A., McHenry C.L., Goldsmith A.M., et al. Nasal cytokine responses to natural colds in asthmatic children. Clin. Exp. Allergy: J. Brit. Soc. Allergy Clin. Immunol. 2012, 42:1734-1744.
29. Gern J.E., Brooks G.D., Meyer P., Chang A., Shen K., Evans M.D., et al. Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life. J. Allergy Clin. Immunol. 2006, 117:72-78.
30. Dakhama A., Lee Y.M., Gelfand E.W. Virus-induced airway dysfunction: pathogenesis and biomechanisms. Pediatr. Infect. Dis. J. 2005, 24:S159-S169. discussion S66-7.
31. Bermejo-Martin J.F., Garcia-Arevalo M.C., De Lejarazu R.O., Ardura J., Eiros J.M., Alonso A., et al. Predominance of Th2 cytokines, CXC chemokines and innate immunity mediators at the mucosal level during severe respiratory syncytial virus infection in children. Eur. Cytokine Netw. 2007, 18:162-167.
32. Martinez-Moczygemba M., Huston D.P. Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J. Allergy Clin. Immunol. 2003, 112:653-665. quiz 66.
33. Legg J.P., Hussain I.R., Warner J.A., Johnston S.L., Warner J.O. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am. J. Respir. Crit. Care Med. 2003, 168:633-639.
34. Bont L., Kavelaars A., Heijnen C.J., van Vught A.J., Kimpen J.L. Monocyte interleukin-12 production is inversely related to duration of respiratory failure in respiratory syncytial virus bronchiolitis. J. Infect. Dis. 2000, 181:1772-1775.
35. Gately M.K., Renzetti L.M., Magram J., Stern A.S., Adorini L., Gubler U., et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 1998, 16:495-521.
36. Gillessen S., Carvajal D., Ling P., Podlaski F.J., Stremlo D.L., Familletti P.C., et al. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 1995, 25:200-206.
37. Podlaski F.J., Nanduri V.B., Hulmes J.D., Pan Y.C., Levin W., Danho W., et al. Molecular characterization of interleukin 12. Arch. Biochem. Biophys. 1992, 294:230-237.
38. Ling P., Gately M.K., Gubler U., Stern A.S., Lin P., Hollfelder K., et al. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 1995, 154:116-127.
39. Piccotti J.R., Chan S.Y., Goodman R.E., Magram J., Eichwald E.J., Bishop D.K. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. J. Immunol. 1996, 157:1951-1957.
40. Duvallet E., Semerano L., Assier E., Falgarone G., Boissier M.C. Interleukin-23: a key cytokine in inflammatory diseases. Ann. Med. 2011, 43:503-511.
41. Mobbs K.J., Smyth R.L., O'Hea U., Ashby D., Ritson P., Hart C.A. Cytokines in severe respiratory syncytial virus bronchiolitis. Pediatr. Pulmonol. 2002, 33:449-452.
42. Kim C.K., Kim S.W., Park C.S., Kim B.I., Kang H., Koh Y.Y. Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis. J. Allergy Clin. Immunol. 2003, 112:64-71.
43. McNamara P.S., Flanagan B.F., Hart C.A., Smyth R.L. Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J. Infect. Dis. 2005, 191:1225-1232.
44. McNamara P.S., Fonceca A.M., Howarth D., Correia J.B., Slupsky J.R., Trinick R.E., et al. Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF. Thorax 2013, 68:76-81.
45. Garcia C., Soriano-Fallas A., Lozano J., Leos N., Gomez A.M., Ramilo O., et al. Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis. Pediatr. Infect. Dis. J. 2012, 31:86-89.
46. Tabarani C.M., Bonville C.A., Suryadevara M., Branigan P., Wang D., Huang D., et al. Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection. Pediatr. Infect. Dis. J. 2013, 32:e437-e442.
47. Garofalo R.P., Patti J., Hintz K.A., Hill V., Ogra P.L., Welliver R.C. Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J. Infect. Dis. 2001, 184:393-399.
48. Noah T.L., Ivins S.S., Murphy P., Kazachkova I., Moats-Staats B., Henderson F.W. Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis. Clin. Immunol. 2002, 104:86-95.
49. Hornsleth A., Loland L., Larsen L.B. Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection. J. Clin. Virol. 2001, 21:163-170.
50. Saenz S.A., Taylor B.C., Artis D. Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol. Rev. 2008, 226:172-190.